Skip to main content
Kala Azar in Bihar, India
Since July 2007, MSF has been running a kala azar diagnostic and treatment project in Vaishali district, in the centre of the Indian state of Bihar. In the four years, about 8,000 patients have been treated at the Sadar Hospital, and in five MSF-supported health centres. The initial cure rate of kala azar cases is at 98 per cent. Kala azar is a disease endemic to Bihar. Transmitted by the sand fly, the disease mainly affects the spleen and, if left untreated, is fatal for virtually all patients.
© Anna Surinyach/MSF

Medicines shouldn't be a luxury

Since July 2007, MSF has been running a kala azar diagnostic and treatment project in Vaishali district, in the centre of the Indian state of Bihar. In the four years, about 8,000 patients have been treated at the Sadar Hospital, and in five MSF-supported health centres. The initial cure rate of kala azar cases is at 98 per cent. Kala azar is a disease endemic to Bihar. Transmitted by the sand fly, the disease mainly affects the spleen and, if left untreated, is fatal for virtually all patients.
© Anna Surinyach/MSF

What if the medicines that could save your life cost a hundred times what you earn in a year?

Many people in developing countries can’t get hold of the treatment they need to stay alive and healthy.

That’s why Médecins Sans Frontières launched the MSF Access Campaign in 1999 to find ways of ensuring that medicines could be made available for all our patients and others in developing countries.

The Access Campaign's mission is to increase access to – and the development of – affordable, practical and effective drugs, vaccines and diagnostic tests for diseases that affect people in places where we work.

Video

Access Campaign

Up Next
India
Press Release 17 June 2013